Fujifilm boosts manufacturing capacity alongside R&D; Baxter International will invest $100M in BioPharma Solutions

SourceEndpoints News
Date Published11/11/2021
Author NameJosh Sullivan
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Fujifilm Irvine Scientific
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Year reshoring announced:2021
Year reshoring implemented or to be implemented:2024
Domestically, the work will be done:In-house
Capital investment ($):100
Country(ies) from which reshored:Japan
City reshored to:Santa Ana
State(s) reshored to:CA
If relevant, work nearshored to:-
Product(s) reshoredbiopharmaceuticals
Find Reshoring Articles